Bayer closes Topsun deal
This article was originally published in The Tan Sheet
Executive Summary
Bayer closes its $157 million acquisition of part of Topsun Science & Technology Qidong Gaitianli Pharmaceutical Co.'s OTC assets, the firms say July 3. Bayer gained the Chinese firm compound pseudoephedrine hydrochloride tablets, which analysts expect to produce $48 million in sales this year. Bayer will also pay a $24 million bonus at the end of the year as part of the deal (1"The Tan Sheet" Oct. 30, 2006, p. 9)...